; Whereas up to an estimated 80 percent of people with acute hepatitis C do not have any symptoms; Whereas African-Americans, Asian-Americans, Pacific Islanders, Latinos, Native Americans, Alaska Natives, gay and bisexual men, and persons who inject drugs intravenously all have higher rates of chronic viral hepatitis infections in the United States than other groups of people; Whereas Asian-Americans and Pacific Islanders bear the greatest burden of hepatitis B-related deaths in the United States; Whereas hepatitis C is 10 times more infectious than human immunodeficiency virus ( HIV ); Whereas hepatitis B is 50 to 100 times more infectious than HIV; Whereas an estimated 25 percent of people who live in the United States and are infected with HIV are also infected with hepatitis C; Whereas life expectancies for persons infected with HIV have increased with antiretroviral treatment, and liver disease, much of which is related to hepatitis B and hepatitis C infections, has become the most common cause of death among this population that is not related to acquired immune deficiency syndrome; Whereas, despite the fact that chronic viral hepatitis is the most common blood-borne infection in the United States, over half of people living with hepatitis B and hepatitis C are unaware of their infection; Whereas hepatitis B is preventable through vaccination, and both hepatitis B and hepatitis C are preventable with proper public health interventions, including programs that offer access to sterile injection equipment for people who inject drugs intravenously; and Whereas the goals of World Hepatitis Day on July 28, 2018, are to— (1) highlight the global nature of chronic viral hepatitis epidemics; (2) recognize that hepatitis can be prevented and eliminated in part through a comprehensive public education and awareness campaign designed to identify those at risk for, and living with, hepatitis; (3) inform patients about new treatments that are available for hepatitis